This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A significant proportion of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) have concomitant coronaryarterydisease (CAD). The best way to treat these patients is contentious.
Congenital Quadricuspid Aortic Valve (QAV) malformation is a relatively rare cardiac valve malformation, especially with abnormal coronary opening and severe stenosis of CoronaryArteryDisease (CAD). The pati.
This genomewide association study examined specific genetic variants, pathways, and tissues associated with aortic stenosis independent of coronaryarterydisease in a meta-analysis of participants from 3 European cohorts.
Of clinical relevance, we observed decreased MICU1 expression in the endothelial layer covering human atherosclerotic plaques and in human aortic endothelial cells exposed to serum from patients with coronaryarterydiseases (CAD).
Background Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy. Coronaryarterydisease (CAD) is frequently found in this patient group and optimal management in these patients remains uncertain.
Transcatheter aortic-valve implantation (TAVI) emerged as a disruptive, revolutionary approach for treating patients with aortic stenosis.1 Should we mimic.
New data reveal that percutaneous coronary intervention (PCI) can be safely performed before, during, or after transcatheter aortic valve replacement (TAVR) for patients with stable coronaryarterydisease (CAD).
Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant CoronaryDisease.
Clinical introduction A woman in her 60s with non-obstructive coronaryarterydisease, aortic valve replacement and aortic arch repair, chronic diastolic heart failure and paroxysmal atrial fibrillation (AF) and flutter (AFL), presented with 3 days of sustained palpitations that felt similar to prior episodes of AF/AFL.
Performing percutaneous coronary intervention (PCI) significantly improved outcomes in patients with stable coronaryarterydisease (CAD) and severe aortic stenosis selected for transcatheter aortic valve implantation (TAVI), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
The goal of the NOTION-3 trial was to evaluate percutaneous coronary intervention (PCI) compared with conservative therapy among patients with obstructive coronaryarterydisease undergoing transcatheter aortic valve implantation (TAVI).
Which genetic and cardiovascular risk factors are aortic stenosis (AS)-specific, and which could be shared between AS and with coronaryarterydisease (CAD)?
The optimal management of concomitant chronic obstructive coronaryarterydisease (CAD) in transcatheter aortic valve replacement (TAVR) recipients remains a debated topic. While some advocate for pre-TAVR percutaneous coronary intervention, others adopt an expectant approach.
Aortic stenosis (AS) due to fibrosis and calcification of the aortic valve is a hazardous component of cardiovascular disease burden—after developing symptomatic AS, patients survive for an average of less than 2 years without treatment.
The role of 4-hydroxynonenal (4-HNE), which is the most abundant stable product of lipid peroxidation, in vascular calcification has been poorly investigated.METHODS:Serum was collected from patients with chronic kidney disease and controls, and the levels of 4-HNE and 8-iso-prostaglandin F2α were measured.
What are clinical outcomes among patients with severe aortic stenosis (AS) and coronaryarterydisease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?
Nature Reviews Cardiology, Published online: 19 September 2024; doi:10.1038/s41569-024-01080-4 In the NOTION-3 trial, percutaneous coronary intervention reduced the occurrence of major adverse cardiac events compared with conservative treatment in patients who were undergoing transcatheter aortic valve implantation for severe aortic stenosis and who (..)
The goal of the TCW trial was to test the noninferiority and, if positive, superiority, of percutaneous coronary intervention (PCI) with transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) and coronaryartery bypass grafting (CABG) in severe aortic stenosis (AS) with comorbid coronaryarterydisease (..)
BackgroundThis Mendelian randomization (MR) study aimed to explore the causal relationship between the genetic predisposition to type 2 diabetes mellitus (T2DM) and aortic dissection (AD), and to assess associations with genetically predicted glycemic traits. The findings remained stable across various MR models and sensitivity analyses.
(MedPage Today) -- PARIS -- For patients with severe aortic stenosis (AS) and concomitant obstructive coronaryarterydisease (CAD), a percutaneous combined intervention worked surprisingly well relative to surgery, the TCW randomized trial found.
Objective To investigate the impact of prior coronaryartery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. The impact of the CABG SYNTAX score was also evaluated in patients with prior CABG.
Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronaryarterydisease, vascular heart disease, debates and games and early career topics. for all attendees.
BackgroundAortic valve calcium score is associated with hemodynamic severity of aortic stenosis. years, 47% of patients were women, 50% had coronaryarterydisease, 40% had atrial fibrillation, 47% had prior cardiac surgery, and 33% had prior chest radiation. Journal of the American Heart Association, Ahead of Print.
The benefit of PCI in patients with stable coronaryarterydisease and severe aortic stenosis who are undergoing transcatheter aortic valve implantation (TAVI) was the focus of the NOTION-3 trial presented at ESC Congress 2024 in London.
Bar plots: in red, patients with low flow-low gradient (LF-LG) aortic stenosis; in blue, patients with normal flow-high gradient (HG) aortic stenosis; in black: controls. Aim Cardiac remodelling plays a major role in the prognosis of patients with aortic stenosis (AS) and could impact the benefits of aortic valve replacement.
Microvascular resistance evaluated whether the vasodilatory reserve capacity of coronary microcirculation was restored in the infarcted territory, regardless of concomitant epicardial coronaryarterydisease and aortic pressure. Transit time is measured by saline bolus injection using a thermodilution technique.
CardioSignal has already developed digital biomarkers for AFib and heart failure, while more solutions could be on the way for aortic stenosis, coronaryarterydisease, and pulmonary artery hypertension.
BackgroundCoronary artery bypass grafting (CABG) surgery has been a widely accepted method for treating coronaryarterydisease. However, its postoperative complications can have a significant effect on long-term patient outcomes.
Cardiovascular disease events (stroke, coronaryarterydisease, congestive heart failure, and aortic dissection) were compared between home SBP subgroups.RESULTS:During mean 5.9
There is increased LV cavity dimensions with an increase in transient ischemic dilation, suggesting Left Main, or 3-vessel coronaryarterydisease. 3. Sudden narrowing of a coronaryartery due to ACS (plaque rupture with thrombosis and/or downstream showering of platelet-fibrin aggregates). Type II ischemia.
2.40];P<0.001), and aortic aneurysm (odds ratio, 1.64 [95% CI, 1.41–1.92];P<0.001). Genetically predicted BMR may not be causally associated with coronaryarterydisease and ischemic stroke risk. 1.67];P<0.001), atrial fibrillation and flutter (odds ratio, 2.12 [95% CI, 1.87–2.40];P<0.001),
The invasive study then investigated the correlations between arterial stiffness, coronary flow reserve and LVFP.Methods:Subjects, referred for coronary angiography were eligible for this study and patients with stenotic lesions coronaryarterydisease (CAD) over 70% in any of which coronary vessels were excluded.
A 79‐year‐old man with a strong family history of arterial dissection, hypertension, coronaryarterydisease, and obesity experienced intense chest pain and left hemiparesis secondary to Type A aortic dissection with extension from the innominate artery to the right carotid bifurcation.
Look at the aortic outflow tract. The diagnostic coronary angiogram identified only minimal coronaryarterydisease, but there was a severely calcified, ‘immobile’ aortic valve. Aortic angiogram did not reveal aortic dissection. What do you see? Answer below in the still shot.
This 3-day event will bring together a world-class, international faculty to explore the latest developments and best practices in coronaryarterydisease, congenital heart disease, thoracic aorticdisease, atrial fibrillation, and the surgical management of heart failure.
An elevated Lp(a) is independently and causally related to early: Coronaryarterydisease Stroke Peripheral Vascular DiseaseAortic Stenosis For a more comprehensive review of what Lp(a) is and why it matters, I have covered this in much more detail here.
Hgb 11g/dL (110g/L) and leukocytosis, and a mildly elevated troponin (36 ng/L, with normal 1mm STE in aVR due to ACS will require coronaryartery bypass surgery for revascularization, the infarct artery is often not the LM, but rather the LAD or severe 3-vessel disease. Incidence of an acute coronary occlusion.
A CT Coronary angiogram was ordered. Here are the results: --Minimally obstructive coronaryarterydisease. --LAD No signs for aortic dissection or pulmonary embolus. --"Results were discussed with the ordering physician. Now, with elevated troponins, Wellens' syndrome is likely. CAD-RADS category 1. --No
Background Pulse pressure (PP), a raw index of arterial stiffness, is inversely related to coronary microvascular function, even among patients with non-obstructive coronaryarterydisease (CAD), as per non-invasive studies. The patients were classified based on whether aortic PP was high (≥50 mm Hg).
Background Coronaryarterydisease (CAD) is a common finding in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). LV ejection fraction and mean aortic gradients were lower in the CTO group. There was also no difference in long-term survival.
VHD incidence was determined using International Classification of Disease-10 codes for aortic stenosis (AS), aortic regurgitation (AR), mitral stenosis, mitral regurgitation (MR) and mitral valve prolapse. Clinical correlates of VHD included demographics, coronaryarterydisease, heart failure and atrial fibrillation.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content